Loading...
Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis
New drugs are needed to control the current tuberculosis (TB) pandemic caused by infection with Mycobacterium tuberculosis. We report here on our work with AX-35, an arylvinylpiperazine amide, and four related analogs, which are potent antitubercular agents in vitro. All five compounds showed good a...
Na minha lista:
| Udgivet i: | mBio |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Microbiology
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6178619/ https://ncbi.nlm.nih.gov/pubmed/30301850 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/mBio.01276-18 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|